Nuvation Bio Inc (NYSE:NUVB) currently has a daily average trading volume of 3.24M but it saw 5341031 shares traded in last market. With a market cap of 765.59M USD, the company’s current market price of $2.25 came rising about 10.84 while comparing to the previous closing price of $2.03. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.97 and as low as $1.54.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Citizens JMP which initiated the stock as “Mkt Outperform” in its note to investors issued on April 23, 2025, recommending a price target of $6 for it. Jefferies upgraded its recommendation for the stock as a “Buy” from “Hold” on March 27, 2024 while assigning a price target range of $1.40-$10. BTIG Research issued its recommendations for the stock as it upgraded the price target for the stock is $5.
Over the week, NUVB’s stock price is moving 0.45% up while it is 8.17% when we observe its performance for the past one month. Year-to-date it is -15.41% down and over the past year, the stock is showing a downside performance of -35.34%.
Currently, Nuvation Bio Inc’s total number of outstanding shares is 338.84M with 19.12% of that held by the insiders while 61.77% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -143.25% and return on equity (ROE) at -119.66%. Stock’s beta reads 1.38. Stock has a price to book (P/B) ratio of 1.82 while price to sale or P/S ratio amounts to 69.85. Its return on asset (ROA) is -109.69% on average.
